China-based biotech company Therorna has secured $42m in a Series A financing round to support its growth and fuel product pipeline development.
21 Jun 2022
20 May 2022
Biotechnology firm Inceptor Bio has raised $37m from Series A funding round that was led by Kineticos Ventures.
10 Nov 2021
Massachusetts-based Arbor Biotechnologies has raised $215m through Series B financing round, and plans to use the proceeds to advance its next-generation precision editing therapeutics.
14 Jul 2021
Biotechnology company Prime Medicine has launched with $315m funding to advance its Prime Editing platform, a next-generation gene editing technology.
12 Mar 2021
A branch of the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) has granted $2.5m to 12 institutes across the world for bacteriophage therapy research.
21 Jan 2021
Akron Biotechnology (Akron Biotech) has signed an exclusive global agreement with Swiss-based Octapharma, to manufacture virally inactivated Human AB Serum for the cell therapy market.
19 Jan 2021
Chinese biotechnology firm Cure Genetics has partnered with Boehringer Ingelheim for the development of novel Adeno-Associated Virus (AAV) vectors to be used in gene therapies.